- 专利标题: STING agonistic compound
-
申请号: US17264179申请日: 2019-10-10
-
公开(公告)号: US11130773B2公开(公告)日: 2021-09-28
- 发明人: Ryosuke Hanada , Masaya Kokubo , Masakuni Kurono , Kenichi Kouda , Hiroshi Hagiya
- 申请人: ONO PHARMACEUTICAL CO., LTD.
- 申请人地址: JP Osaka
- 专利权人: ONO PHARMACEUTICAL CO., LTD.
- 当前专利权人: ONO PHARMACEUTICAL CO., LTD.
- 当前专利权人地址: JP Osaka
- 代理机构: Sughrue Mion, PLLC
- 优先权: JPJP2018-192276 20181011
- 国际申请: PCT/JP2019/039941 WO 20191010
- 国际公布: WO2020/075790 WO 20200416
- 主分类号: C07F9/6561
- IPC分类号: C07F9/6561
摘要:
A drug or agent containing a compound having an agonistic activity to STING as an active ingredient, where the compound is represented by the following general formula (I-1): wherein all symbols represent the same meanings as described in the specification, and the compound can be used as an active ingredient of an agent for suppressing the progression of, suppressing the recurrence of and/or treating cancer or infectious disease.
公开/授权文献
- US20210253615A1 STING AGONISTIC COMPOUND 公开/授权日:2021-08-19
信息查询